Snowball logo
logo
AVIR

Atea Pharmaceuticals, Inc

AVIR β€’ NASDAQ
$4.99+$0.08Β  (1.63%)

Frequently asked questions

What sector does Atea Pharmaceuticals, Inc (AVIR) operate in?

Atea Pharmaceuticals, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Atea Pharmaceuticals, Inc (AVIR) current stock price?

As of the latest data, Atea Pharmaceuticals, Inc stock price is $4.99, with a previous close of $4.91. Atea Pharmaceuticals, Inc gained $0.08 in the last trading session, representing a 1.63% increase.

What is Atea Pharmaceuticals, Inc (AVIR) current market capitalization?

Atea Pharmaceuticals, Inc market cap is approximately 399.34 million.

What is Atea Pharmaceuticals, Inc (AVIR) Earnings Per Share (EPS)?

The trailing EPS is -$2.11, and the forward EPS is -$1.39.

What is Atea Pharmaceuticals, Inc (AVIR) EBITDA?

Atea Pharmaceuticals, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -45.29 million.

Does Atea Pharmaceuticals, Inc (AVIR) pay dividends?

No. Atea Pharmaceuticals, Inc does not pay a dividend.

When is Atea Pharmaceuticals, Inc (AVIR) next earnings report?

Atea Pharmaceuticals, Inc is expected to release its next earnings report on June 30, 2026.

What is Atea Pharmaceuticals, Inc (AVIR) beta (volatility) score?

Atea Pharmaceuticals, Inc has a beta of 0.316, indicating lower volatility than the overall market.